{"transactions":[{"id":1693063,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:42:10.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":18440,"price":3.33,"value":61405.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,826 shares acquired on November 15, 2023, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan and includes the cancellation of 13,333 restricted stock units."}],"balance_after":75305,"source":{"system":"sec-edgar","filing":"0001610717-24-000001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000161071724000001/form4.xml","form_type":"4"}},{"id":1854592,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T16:40:33.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001610717-23-000166","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000161071723000166/form4.xml","form_type":"4"}},{"id":1928719,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-04T20:56:05.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3457,"price":6.84,"value":23645.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,466 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":102252,"source":{"system":"sec-edgar","filing":"0001140361-23-016453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000114036123016453/form4.xml","form_type":"4"}},{"id":2047581,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-24T16:45:40.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":104243,"source":{"system":"sec-edgar","filing":"0001567619-23-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761923001207/doc1.xml","form_type":"4"}},{"id":2060615,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T18:14:54.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":9.87,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-23-000695","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761923000695/doc1.xml","form_type":"4"}},{"id":2060614,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-06T18:14:54.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":5437,"price":9.87,"value":53663.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":64243,"source":{"system":"sec-edgar","filing":"0001567619-23-000695","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761923000695/doc1.xml","form_type":"4"}},{"id":2304853,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T17:19:55.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":3458,"price":12.85,"value":44435.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":69680,"source":{"system":"sec-edgar","filing":"0001567619-22-008114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761922008114/doc1.xml","form_type":"4"}},{"id":2441788,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T19:50:10.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-22-000820","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761922000820/doc1.xml","form_type":"4"}},{"id":2441787,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-06T19:50:10.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,000 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,527 shares acquired on November 15, 2021, pursuant to Issuer's employee stock purchase plan."}],"balance_after":73138,"source":{"system":"sec-edgar","filing":"0001567619-22-000820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761922000820/doc1.xml","form_type":"4"}},{"id":2539489,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T19:36:01.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":3507,"price":16.8003,"value":58918.6521,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,000 RSUs."}],"balance_after":31611,"source":{"system":"sec-edgar","filing":"0001567619-21-018470","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761921018470/doc1.xml","form_type":"4"}},{"id":2674195,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-10T16:35:47.000Z","date":"2021-06-09","kind":"purchase","acquired":true,"shares":3700,"price":13.4237,"value":49667.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $13.415 to $13.4294, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,418 shares acquired on May 14, 2021, pursuant to Issuer's employee stock purchase plan."}],"balance_after":35118,"source":{"system":"sec-edgar","filing":"0001567619-21-011972","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761921011972/doc1.xml","form_type":"4"}},{"id":2734693,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-30T16:38:24.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 8, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":14.76,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-008804","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761921008804/doc1.xml","form_type":"4"}},{"id":2734692,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-30T16:38:24.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on April 1 of each year, with the first 1/2 vesting on April 1, 2022 and with the RSUs being fully vested on April 1, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 RSUs."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001567619-21-008804","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000156761921008804/doc1.xml","form_type":"4"}}]}